These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 7684925)
1. Probing hydration contributions to the thermodynamics of ligand binding by proteins. Enthalpy and heat capacity changes of tacrolimus and rapamycin binding to FK506 binding protein in D2O and H2O. Connelly PR; Thomson JA; Fitzgibbon MJ; Bruzzese FJ Biochemistry; 1993 Jun; 32(21):5583-90. PubMed ID: 7684925 [TBL] [Abstract][Full Text] [Related]
2. Heat capacity changes and hydrophobic interactions in the binding of FK506 and rapamycin to the FK506 binding protein. Connelly PR; Thomson JA Proc Natl Acad Sci U S A; 1992 Jun; 89(11):4781-5. PubMed ID: 1375751 [TBL] [Abstract][Full Text] [Related]
3. Enthalpy of hydrogen bond formation in a protein-ligand binding reaction. Connelly PR; Aldape RA; Bruzzese FJ; Chambers SP; Fitzgibbon MJ; Fleming MA; Itoh S; Livingston DJ; Navia MA; Thomson JA Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1964-8. PubMed ID: 7510408 [TBL] [Abstract][Full Text] [Related]
4. Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin. Van Duyne GD; Standaert RF; Karplus PA; Schreiber SL; Clardy J J Mol Biol; 1993 Jan; 229(1):105-24. PubMed ID: 7678431 [TBL] [Abstract][Full Text] [Related]
5. Analogous conformations of both binding and effector regions in cyclosporin A, FK506 and rapamycin. Denesyuk AI; Denessiouk KA; Zav'yalov VP; Lundell J; Korpela T Comput Chem; 1998 Jun; 22(4):339-44. PubMed ID: 9680690 [TBL] [Abstract][Full Text] [Related]
6. FK506-binding protein mutational analysis: defining the active-site residue contributions to catalysis and the stability of ligand complexes. DeCenzo MT; Park ST; Jarrett BP; Aldape RA; Futer O; Murcko MA; Livingston DJ Protein Eng; 1996 Feb; 9(2):173-80. PubMed ID: 9005438 [TBL] [Abstract][Full Text] [Related]
7. Complete amino acid sequence of the FK506 and rapamycin binding protein, FKBP, isolated from calf thymus. Lane WS; Galat A; Harding MW; Schreiber SL J Protein Chem; 1991 Apr; 10(2):151-60. PubMed ID: 1718307 [TBL] [Abstract][Full Text] [Related]
8. Mean field analysis of FKBP12 complexes with FK506 and rapamycin: implications for a role of crystallographic water molecules in molecular recognition and specificity. Rejto PA; Verkhivker GM Proteins; 1997 Jul; 28(3):313-24. PubMed ID: 9223178 [TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of a rapamycin-based high affinity binding FKBP12 ligand. Chakraborty TK; Weber HP; Nicolaou KC Chem Biol; 1995 Mar; 2(3):157-61. PubMed ID: 9383417 [TBL] [Abstract][Full Text] [Related]
10. Conformational polymorphism in peptidic and nonpeptidic drug molecules. Taylor P; Mikol V; Kallen J; Burkhard P; Walkinshaw MD Biopolymers; 1996; 40(5):585-92. PubMed ID: 9101762 [TBL] [Abstract][Full Text] [Related]
11. Solution structure of FKBP, a rotamase enzyme and receptor for FK506 and rapamycin. Michnick SW; Rosen MK; Wandless TJ; Karplus M; Schreiber SL Science; 1991 May; 252(5007):836-9. PubMed ID: 1709301 [TBL] [Abstract][Full Text] [Related]
12. Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action. Bierer BE Chem Immunol; 1994; 59():128-55. PubMed ID: 7524531 [No Abstract] [Full Text] [Related]
13. The chemistry of signal transduction. Clardy J Proc Natl Acad Sci U S A; 1995 Jan; 92(1):56-61. PubMed ID: 7529414 [TBL] [Abstract][Full Text] [Related]
14. Hepatotrophic properties in dogs of human FKBP, the binding protein for FK506 and rapamycin. Starzl TE; Schreiber SL; Albers MW; Porter KA; Foglieni CS; Francavilla A Transplantation; 1991 Oct; 52(4):751-3. PubMed ID: 1718068 [No Abstract] [Full Text] [Related]
15. Mechanism for the rotamase activity of FK506 binding protein from molecular dynamics simulations. Orozco M; Tirado-Rives J; Jorgensen WL Biochemistry; 1993 Nov; 32(47):12864-74. PubMed ID: 8251509 [TBL] [Abstract][Full Text] [Related]
16. Stabilization of the FK506 binding protein by ligand binding. Marquis-Omer D; Sanyal G; Volkin DB; Marcy AI; Chan HK; Ryan JA; Middaugh CR Biochem Biophys Res Commun; 1991 Sep; 179(2):741-8. PubMed ID: 1716886 [TBL] [Abstract][Full Text] [Related]
17. A novel FK506- and rapamycin-binding protein (FPR3 gene product) in the yeast Saccharomyces cerevisiae is a proline rotamase localized to the nucleolus. Benton BM; Zang JH; Thorner J J Cell Biol; 1994 Nov; 127(3):623-39. PubMed ID: 7525596 [TBL] [Abstract][Full Text] [Related]
18. Catalytic and ligand binding properties of the FK506 binding protein FKBP12: effects of the single amino acid substitution of Tyr82 to Leu. Bossard MJ; Bergsma DJ; Brandt M; Livi GP; Eng WK; Johnson RK; Levy MA Biochem J; 1994 Jan; 297 ( Pt 2)(Pt 2):365-72. PubMed ID: 7507662 [TBL] [Abstract][Full Text] [Related]
19. Structure comparison of native and mutant human recombinant FKBP12 complexes with the immunosuppressant drug FK506 (tacrolimus). Itoh S; Navia MA Protein Sci; 1995 Nov; 4(11):2261-8. PubMed ID: 8563622 [TBL] [Abstract][Full Text] [Related]
20. Immunological identification of a 50 kDa Mr FK506-binding immunophilin as a component of the non-DNA binding, hsp90 and hsp70 containing, heterooligomeric form of the chick oviduct progesterone receptor. Renoir JM; Pahl A; Keller U; Baulieu EE C R Acad Sci III; 1993 Dec; 316(12):1410-6. PubMed ID: 7522118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]